Exelixis (EXEL) — insider trading
Health Care
Exelixis (EXEL) has 12 reported SEC Form 4 insider transactions in our data, including 2 open-market sales among the most recent 12 (latest 2026-06-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Eckhardt Sue Gail | Director | Open-market sale | 9,812 | $50.14 | $492.0K | Form 4 |
| 2026-06-01 | WYSZOMIERSKI JACK L | Director | Open-market sale | 3,925 | $50.55 | $198.4K | Form 4 |
| 2026-05-27 | JOHNSON DAVID EDWARD; Caligan Partners LP | Director | Grant / award / vesting (derivative) | 19,133 | $0.00 | $0 | Form 4 |
| 2026-05-27 | POSTE GEORGE | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | WYSZOMIERSKI JACK L | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | Oliver Bob | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | Beckerle Mary C | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | Freire Maria C | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | Smith Julie | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | Eckhardt Sue Gail | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | Heyman Tomas J. | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
| 2026-05-27 | PAPADOPOULOS STELIOS | Director | Grant / award / vesting | 8,367 | $0.00 | $0 | Form 4 |
Ask the chat about EXEL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Exelixis (EXEL).
Last updated 2026-06-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.